| Michael Anthony Sabol, DPT | |
|
37464 Lion Dr, Unit 4, Selbyville, DE 19975 | |
| (302) 988-1586 | |
| (302) 988-1593 |
| Full Name | Michael Anthony Sabol |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 12 Years |
| Location | 37464 Lion Dr, Selbyville, Delaware |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376805861 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | J1-0003035 (Delaware) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dynamic Therapy Services Llc | 0749283083 | 111 |
News Archive
Celtaxsys, Inc. a privately held biotechnology company, announced today that it has acquired CTX-4430 (formerly EP-501), a clinical stage drug candidate that inhibits the pro-inflammatory enzyme Leukotriene A4 Hydrolase (LTA4H), from Estrellita Pharmaceuticals, Inc.
MEMS industry execs attending the annual MEMS Executive Congress last week were rapt by presentations and panel discussions by leading innovators in automotive, bio/medical, consumer electronics, mobile communications and energy. Buoyed by optimistic forecasts for microelectromechanical systems (MEMS) devices such as accelerometers and multi-axis gyros—increasingly used in mobile handsets and video games—they engaged with keynote speaker Dr. Mauro Ferrari, professor and director of The Division of NanoMedicine and Deputy Chairman of The University of Texas Department of Biomedical Engineering, whose proteomic NanoChips and multi-stage drug-delivery systems may one day ‘cure cancer.'
Depending on the analysis strategy used, estimating treatment outcomes in metaanalyses may differ and may result in major alterations in the conclusions derived from the analysis, according to a study in the August 13 issue of JAMA.
Taking a daily multivitamin containing the B vitamin folic acid is one of the best ways to prevent birth defects and an important step toward having a healthy baby, yet only about one-third of women know about it.
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.
› Verified 9 days ago
| Provider Name | Dynamic Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205875093 PECOS PAC ID: 0749283083 Enrollment ID: O20060831000322 |
News Archive
Celtaxsys, Inc. a privately held biotechnology company, announced today that it has acquired CTX-4430 (formerly EP-501), a clinical stage drug candidate that inhibits the pro-inflammatory enzyme Leukotriene A4 Hydrolase (LTA4H), from Estrellita Pharmaceuticals, Inc.
MEMS industry execs attending the annual MEMS Executive Congress last week were rapt by presentations and panel discussions by leading innovators in automotive, bio/medical, consumer electronics, mobile communications and energy. Buoyed by optimistic forecasts for microelectromechanical systems (MEMS) devices such as accelerometers and multi-axis gyros—increasingly used in mobile handsets and video games—they engaged with keynote speaker Dr. Mauro Ferrari, professor and director of The Division of NanoMedicine and Deputy Chairman of The University of Texas Department of Biomedical Engineering, whose proteomic NanoChips and multi-stage drug-delivery systems may one day ‘cure cancer.'
Depending on the analysis strategy used, estimating treatment outcomes in metaanalyses may differ and may result in major alterations in the conclusions derived from the analysis, according to a study in the August 13 issue of JAMA.
Taking a daily multivitamin containing the B vitamin folic acid is one of the best ways to prevent birth defects and an important step toward having a healthy baby, yet only about one-third of women know about it.
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Anthony Sabol, DPT 350 New Fidelity Ct, Garner, NC 27529-2665 Ph: (919) 258-2714 | Michael Anthony Sabol, DPT 37464 Lion Dr, Unit 4, Selbyville, DE 19975 Ph: (302) 988-1586 |
News Archive
Celtaxsys, Inc. a privately held biotechnology company, announced today that it has acquired CTX-4430 (formerly EP-501), a clinical stage drug candidate that inhibits the pro-inflammatory enzyme Leukotriene A4 Hydrolase (LTA4H), from Estrellita Pharmaceuticals, Inc.
MEMS industry execs attending the annual MEMS Executive Congress last week were rapt by presentations and panel discussions by leading innovators in automotive, bio/medical, consumer electronics, mobile communications and energy. Buoyed by optimistic forecasts for microelectromechanical systems (MEMS) devices such as accelerometers and multi-axis gyros—increasingly used in mobile handsets and video games—they engaged with keynote speaker Dr. Mauro Ferrari, professor and director of The Division of NanoMedicine and Deputy Chairman of The University of Texas Department of Biomedical Engineering, whose proteomic NanoChips and multi-stage drug-delivery systems may one day ‘cure cancer.'
Depending on the analysis strategy used, estimating treatment outcomes in metaanalyses may differ and may result in major alterations in the conclusions derived from the analysis, according to a study in the August 13 issue of JAMA.
Taking a daily multivitamin containing the B vitamin folic acid is one of the best ways to prevent birth defects and an important step toward having a healthy baby, yet only about one-third of women know about it.
TxCell SA, a biotech developing innovative, personalized cell-based immunotherapies using antigen-specific regulatory T-cells (Ag-Tregs) for chronic inflammatory and autoimmune diseases, announces today the launch of, and funding awarded to, the POSITIVE project in collaboration with the Gene and Cell therapy Unit (UTCG) developing new antiviral cell-based immunotherapies and Biosafe, a Swiss private company, a developer of innovative solutions for cell processing.
› Verified 9 days ago
Coastal Care Physical Therapy Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 6 Ellis Alley, Unit 6, Selbyville, DE 19975 Phone: 302-524-8333 Fax: 302-524-8891 | |
Lisa Ash, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6 Ellis Alley Unit 6, Selbyville, DE 19975 Phone: 302-524-8333 Fax: 302-524-8891 | |
Dominick Andrew Policare, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 37031 Old Mill Bridge Rd Unit 2, Selbyville, DE 19975 Phone: 410-208-3630 | |
Cindy Popelas, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 31 Hosier St, Selbyville, DE 19975 Phone: 302-436-1000 | |
Dynamic Therapy Services, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 37464 Lion Dr, Ste 4, Selbyville, DE 19975 Phone: 302-988-1586 Fax: 302-988-1593 | |
Christine Anne Weber, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 37464 Lion Drive, Suite 4, Selbyville, DE 19975 Phone: 302-988-1586 Fax: 302-988-1593 | |
Maricryst Birao, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 6 Ellis Alley Unit 6, Selbyville, DE 19975 Phone: 302-524-8333 Fax: 302-524-8891 |